rs111228504
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004369.4(COL6A3):c.6156+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 1,613,656 control chromosomes in the GnomAD database, including 131 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004369.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.6156+4C>T | splice_region_variant, intron_variant | ENST00000295550.9 | NP_004360.2 | |||
COL6A3 | NM_057167.4 | c.5538+4C>T | splice_region_variant, intron_variant | NP_476508.2 | ||||
COL6A3 | NM_057166.5 | c.4335+4C>T | splice_region_variant, intron_variant | NP_476507.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A3 | ENST00000295550.9 | c.6156+4C>T | splice_region_variant, intron_variant | 1 | NM_004369.4 | ENSP00000295550.4 | ||||
COL6A3 | ENST00000472056.5 | c.4335+4C>T | splice_region_variant, intron_variant | 1 | ENSP00000418285.1 | |||||
COL6A3 | ENST00000353578.9 | c.5538+4C>T | splice_region_variant, intron_variant | 5 | ENSP00000315873.4 |
Frequencies
GnomAD3 genomes AF: 0.00902 AC: 1372AN: 152132Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.0114 AC: 2875AN: 251462Hom.: 25 AF XY: 0.0121 AC XY: 1638AN XY: 135910
GnomAD4 exome AF: 0.0117 AC: 17064AN: 1461408Hom.: 124 Cov.: 31 AF XY: 0.0118 AC XY: 8567AN XY: 727054
GnomAD4 genome AF: 0.00900 AC: 1370AN: 152248Hom.: 7 Cov.: 32 AF XY: 0.00817 AC XY: 608AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 13, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 15, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Bethlem myopathy 1A Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | COL6A3: BP4, BS1, BS2 - |
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at